RSS

Novo Nordisk

Novo Nordisk, global healthcare company, has acquired all of the shares of a University of Bristol spin-out company — Ziylo — giving it full rights to a glucose blinding molecule platform to develop glucose responsive insulins. Read more

News

Global healthcare company, Novo Nordisk, has revealed that the US Food and Drug Administration (FDA) has approved its fast-acting mealtime insulin, Fiasp, for the improvement of glycaemic control in adults with diabetes. Read more

Technology

Apps are ever more popular and becoming part of daily routine and lifestyle in this digital age, but how are pharma companies measuring up in this space? Read more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

A company-led product recall by Novo Nordisk has been announced for certain batches of its NovoPen Echo and NovoPen 5 products, according to a press release from the Medicines and Healthcare products Regulatory Agency (MHRA). Read more

Technology

Global healthcare company, Novo Nordisk, and digital platform and data analytics company, Glooko, have launched an integrated app to help people manage diabetes called Cornerstones4Care (C4C). Read more

Technology

Global healthcare company Novo Nordisk, alongside global pharmaceutical company Pfizer, are investing $9 million into the Swedish-based digital health company AMRA. Read more

News

Multinational pharmaceutical firm Novo Nordisk has announced that it will collaborate with remote patient monitoring provider Glooko. Read more

News

Analyst company GBI Research has concluded that due to an increasing demand for type 2 diabetes mellitus (T2DM) therapeutics, there is a large and competitive market landscape. Read more

News

Abbvie, Sanofi and Novo Nordisk seens as most reputable pharma companies in the UK and industry as a whole ranked third most reputable by general public Read more

News

As always innovation has been a key element in this year’s pharmaceutical sector. Lu Rahman handpicks her favourite stories showing the breakthroughs that have taken place over the last 12 months Read more

Opinion

Novo Nordisk has submitted a New Drug Application (NDA) for a faster-acting insulin aspart to the US Food and Drug Administration (FDA) Read more

News

Ablynx and Novo Nordisk will collaborate to discover and develop multi-specific nanobody drug candidates with an option to expand the agreement to include a second nanobody programme Read more

News

Y. Shashidhar, partner & managing director, South Asia, Middle East & North Africa, Frost & Sullivan talks about how the local production of insulin from Novo Nordisk’s new plant in Iran could impact the pharma market Read more

Opinion

Novo Nordisk has announced a research collaboration with the Langer Laboratory at the Massachusetts Institute of Technology (MIT) for the next generation of drug delivery devices for the administration of peptides Read more

News

The latest interim data from the guardian2 extension trial for Novo Nordisk NovoEight showed that in a phase 3 trial, long-term efficacy and safety in the prophylaxis and treatment of bleeds was achieved in people with severe haemophilia A. Read more

News

New findings showed that adults with type 2 diabetes treated with Victoza, in combination with metformin, experienced similar improvements in blood glucose control while fasting during Ramadan compared with sulfonylurea plus metformin. Read more

News

FeF Chemicals is a Novo Nordisk company specialising in the supply of ingredients for the pharmaceutical and biopharmaceutical industries. Read more

News

Novo Nordisk has announced that CHMP has adopted a positive opinion for Xultophy, the first ever once-daily basal insulin and GLP-1 analogue in one pen. Read more

Up to 2022, Novo Nordisk expects to hire 6000 new employees in Denmark, half of whom will work within research and development. Read more